References
- Bulun SE. Endometriosis. N Engl J Med 2009;360:268–79.
- Chapron C, Santulli P, Cabri P. The pain and daily consequences of living with endometriosis: a qualitative online survey of women in China, France and Russia. J Endometr Pelvic Pain Disord 2015;7:89.
- Reis FM, Petraglia F, Taylor RN. Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis. Hum Reprod Update 2013;19:406–18.
- Rocha AL, Reis FM, Taylor RN. Angiogenesis and endometriosis. Obstet Gynecol Int 2013;2013:859619.
- Donaldson CJ, Sutton SW, Perrin MH, et al. Cloning and characterization of human urocortin. Endocrinology 1996;137:3896.
- Torricelli M, De Falco G, Florio P, et al. Secretory endometrium highly expresses urocortin messenger RNA and peptide: possible role in the decidualization process. Hum Reprod 2007;22:92–6.
- Florio P, Bruni L, De Falco C, et al. Evaluation of endometrial urocortin secretion for prediction of pregnancy after intrauterine insemination. Clin Chem 2008;54:350–5.
- Florio P, Vale W, Petraglia F. Urocortins in human reproduction. Peptides 2004;25:1751–7.
- Novembri R, Borges LE, Carrarelli P, et al. Impaired CRH and urocortin expression and function in eutopic endometrium of women with endometriosis. J Clin Endocrinol Metab 2011;96:1145–50.
- Vergetaki A, Jeschke U, Vrekoussis T, et al. Differential expression of CRH, UCN, CRHR1 and CRHR2 in eutopic and ectopic endometrium of women with endometriosis. PLoS One 2013;8:e62313.
- Carrarelli P, Luddi A, Funghi L, et al. Urocortin and corticotrophin-releasing hormone receptor type 2 mRNA are highly expressed in deep infiltrating endometriotic lesions. Reprod Biomed Online 2016;33:476–83.
- Luisi S, Pinzauti S, Regini C, Petraglia F. Serum markers for the noninvasive diagnosis of endometriosis. Womens Health (Lond) 2015;11:603–10.
- Fassbender A, Burney RO, O DF, et al. Update on biomarkers for the detection of endometriosis. Biomed Res Int 2015;2015:130854.
- Rogers PA, D'Hooghe TM, Fazleabas A, et al. Defining future directions for endometriosis research: workshop report from the 2011 World Congress of Endometriosis In Montpellier, France. Reprod Sci 2013;20:483–99.
- Florio P, Reis FM, Torres PB, et al. Plasma urocortin levels in the diagnosis of ovarian endometriosis. Obstet Gynecol 2007;110:594–600.
- Rocha AL, Vieira EL, Maia LM, et al. Prospective evaluation of a panel of plasma cytokines and chemokines as potential markers of pelvic endometriosis in symptomatic women. Gynecol Obstet Invest 2016;81:512–17.
- Borges LE, Bloise E, Dela Cruz C, et al. Urocortin 1 expression and secretion by human umbilical vein endothelial cells: In vitro effects of interleukin 8, interferon gamma, lipopolysaccharide, endothelin 1, prostaglandin F-2alpha, estradiol, progesterone and dexamethasone. Peptides 2015;74:64–9.
- Lauria PB, Del Puerto HL, Reis AM, et al. Low plasma atrial natriuretic peptide: a new piece in the puzzle of polycystic ovary syndrome. J Clin Endocrinol Metab 2013;98:4882–9.
- Reis FM, Monteiro CS, Carneiro MM. Biomarkers of pelvic endometriosis. Rev Bras Ginecol Obstet 2017;39:91–3.
- Fekete EM, Zorrilla EP. Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs. Front Neuroendocrinol 2007;28:1–27.
- Chiantera V, Abesadze E, Mechsner S. How to understand the complexity of endometriosis-related pain. J Endometr Pelvic Pain Disord 2017;9:30–8.
- Staal AH, van der Zanden M, Nap AW. Diagnostic delay of endometriosis in the Netherlands. Gynecol Obstet Invest 2016;81:321–4.
- May KE, Conduit-Hulbert SA, Villar J, et al. Peripheral biomarkers of endometriosis: a systematic review. Hum Reprod Update 2010;16:651–74.